Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells

The aim of these studies was to characterize the molecular pharmacology of the prostanoid receptors positively coupled to stimulation of adenylyl cycl ase activity in immortalized human trabecular meshwork (TM-3) cells and to compare these results with that of the receptors in immortalized human nonp igmented epithelial (NPE) cells. In general, the TM-3 and NPE cells showed a similar profile with respect to their responses to various prostaglandin (PG) receptor agonists. The rank order of potency (EC50; means +/- SEM) for these compounds in the TM-3 cells was: PGE(2) (124 +/- 21 nM) > 13,14-dihy dro-PGE(1) (430 +/- 110 nM) = PGE(1) (522 +/- 345 nM) > 11-deoxy-PGE(1) (10 63 +/- 118 nM) = 16,16-dimethyl-PGE(2) (1776 +/- 460 nM) = butaprost (1920 +/- 527 nM) >> PGD(2) = PGI(2) = PGF(2 alpha) (n = 3 - 12). While the agoni st profile indicated the presence of EP2 receptors, the effects: of the EP4 receptor antagonists suggested the additional expression of EP4 receptors in both of these cells. Thus, the EP4 receptor antagonist, AH23848B, at a c oncentration of 30 muM, caused a dextral shift in the PGE(2) concentration- response curves in both TM-3 and NPE, cells coupled with a 20-28% decrease in the maximal response of PGE2, indicating apparent noncompetitive antagon ism profiles. The antagonist potency of AH23848B in these cells was: K-b = 38.4 +/- 14.8 muM and 23.5 +/- 4.5 muM; -log K-b = 4.7. The other EP4 recep tor antagonist, AH172921 (-log K-b = 4.1 - 4.7), was weaker than AH23848B. Taken together, these pharmacological studies have shown than TM-3 and NPE cells apparently contain Functional EP2 and EP4 prostanoid receptors positi vely coupled to adenylyl cyclase.